Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 312

    1.

    Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure.

    Stangle DE, Strawderman MS, Smith D, Kuypers M, Strupp BJ.

    Environ Health Perspect. 2004 Mar;112(3):302-8.PMID: 14998744 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.

    Smith D, Bayer L, Strupp BJ.

    Environ Res. 1998 Aug;78(2):168-76.PMID: 9719621 [PubMed - indexed for MEDLINE]Related articles

    3.

    Efficacy of succimer chelation for reducing brain lead in a primate model of human lead exposure.

    Cremin JD Jr, Luck ML, Laughlin NK, Smith DR.

    Toxicol Appl Pharmacol. 1999 Dec 15;161(3):283-93.PMID: 10620486 [PubMed - indexed for MEDLINE]Related articles

    4.

    Succimer and the reduction of tissue lead in juvenile monkeys.

    Smith DR, Woolard D, Luck ML, Laughlin NK.

    Toxicol Appl Pharmacol. 2000 Aug 1;166(3):230-40.PMID: 10906287 [PubMed - indexed for MEDLINE]Related articles

    5.

    Succimer chelation improves learning, attention, and arousal regulation in lead-exposed rats but produces lasting cognitive impairment in the absence of lead exposure.

    Stangle DE, Smith DR, Beaudin SA, Strawderman MS, Levitsky DA, Strupp BJ.

    Environ Health Perspect. 2007 Feb;115(2):201-9. Epub 2006 Oct 30.PMID: 17384765 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.

    Dietrich KN, Ware JH, Salganik M, Radcliffe J, Rogan WJ, Rhoads GG, Fay ME, Davoli CT, Denckla MB, Bornschein RL, Schwarz D, Dockery DW, Adubato S, Jones RL; Treatment of Lead-Exposed Children Clinical Trial Group.

    Pediatrics. 2004 Jul;114(1):19-26.PMID: 15231903 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats.

    Beaudin SA, Stangle DE, Smith DR, Levitsky DA, Strupp BJ.

    Neurotoxicol Teratol. 2007 Mar-Apr;29(2):188-202. Epub 2006 Nov 18.PMID: 17196787 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.

    Bradberry S, Vale A.

    Clin Toxicol (Phila). 2009 Aug;47(7):617-31. Review.PMID: 19663612 [PubMed - indexed for MEDLINE]Related articles

    9.

    The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead.

    Rogan WJ, Dietrich KN, Ware JH, Dockery DW, Salganik M, Radcliffe J, Jones RL, Ragan NB, Chisolm JJ Jr, Rhoads GG; Treatment of Lead-Exposed Children Trial Group.

    N Engl J Med. 2001 May 10;344(19):1421-6.PMID: 11346806 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.

    Cremin JD Jr, Luck ML, Laughlin NK, Smith DR.

    Environ Health Perspect. 2001 Jun;109(6):613-9.PMID: 11445516 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning]

    Yu GY, Yan CH, Yu XG, Zuo Y, Zou XY, Xu J, Wu SH, Shen XM.

    Zhonghua Yu Fang Yi Xue Za Zhi. 2009 Jan;43(1):8-13. Chinese. PMID: 19534872 [PubMed - indexed for MEDLINE]Related articles

    12.

    Succimer and the urinary excretion of essential elements in a primate model of childhood lead exposure.

    Smith DR, Calacsan C, Woolard D, Luck M, Cremin J, Laughlin NK.

    Toxicol Sci. 2000 Apr;54(2):473-80.PMID: 10774830 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The effects of succimer chelation therapy on auditory function in rhesus monkeys.

    Lasky RE, Luck ML, Laughlin NK.

    Neurotoxicol Teratol. 2001 Nov-Dec;23(6):651-8.PMID: 11792533 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.

    Flora SJ, Pande M, Kannan GM, Mehta A.

    Cell Mol Biol (Noisy-le-grand). 2004;50 Online Pub:OL543-51.PMID: 15555419 [PubMed - indexed for MEDLINE]Related articles

    15.

    The effects of elevated blood lead levels and succimer chelation therapy on physical growth in developing rhesus monkeys.

    Lasky RE, Laughlin NK, Luck ML.

    Environ Res. 2001 Sep;87(1):21-30.PMID: 11534961 [PubMed - indexed for MEDLINE]Related articles

    16.

    A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.

    Bradberry S, Vale A.

    Clin Toxicol (Phila). 2009 Nov;47(9):841-58. Review.PMID: 19852620 [PubMed - indexed for MEDLINE]Related articles

    17.

    Use of orally administered succimer (meso-2,3-dimercaptosuccinic acid) for treatment of lead poisoning in dogs.

    Ramsey DT, Casteel SW, Faggella AM, Chastain CB, Nunn JW, Schaeffer DJ.

    J Am Vet Med Assoc. 1996 Feb 1;208(3):371-5.PMID: 8575967 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.

    Cory-Slechta DA.

    J Pharmacol Exp Ther. 1988 Jul;246(1):84-91.PMID: 2839672 [PubMed - indexed for MEDLINE]Related articles

    20.

    Succimer treatment and calcium supplementation reduce tissue lead in suckling rats.

    Marija Varnai V, Piasek M, Blanusa M, Matek Sarić M, Juresa D, Kostial K.

    J Appl Toxicol. 2004 Mar-Apr;24(2):123-8.PMID: 15052607 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data